Laboratoires Thea

This study tested cyclosporin 0.1% eye drops in 25 adults with moderate to severe dry eye disease that didn't get better with artificial tears. The goal was to see if the drops reduce eye dryness and redness. Participants used the drops alongside their usual tear substitutes for …

This completed Phase 2 trial tested two strengths of a new eye drop called T4090 against the existing drug Rhopressa in 161 adults with open-angle glaucoma or ocular hypertension. The goal was to see which better lowers eye pressure over 7 weeks. Participants used one drop daily …

This study tested whether a new eye drop called T2769 works as well as a commonly used one (Vismed Multi) for people with moderate to severe dry eye. 251 adults used the drops for 35 days. The main goal was to see if T2769 could reduce eye surface damage as effectively as Vismed …

This study tested whether a new eye drop called T2769 works as well as a standard treatment (Hylo-Forte) for people with moderate to severe dry eye. 74 adults who still had dry eye symptoms despite using artificial tears took part. The main goal was to see if T2769 could reduce e…

This study tested a new preservative-free eye drop (Thealoz Total) in 30 adults with chronic dry eye and eye redness. Participants used the drops daily for 12 weeks. Researchers measured changes in redness and how satisfied patients felt. The goal was to see if the drops improve …